595 filings
Page 23 of 30
8-K
sadnz
5 Mar 15
Galena Biopharma Reports Fourth Quarter and Year End 2014 Financial Results
12:00am
8-K
p746m825gc6
9 Feb 15
Galena Biopharma Enrolls 700th Patient in NeuVax™ (nelipepimut-S) Phase 3 PRESENT Clinical Trial
12:00am
8-K
kmphp
14 Jan 15
Other Events
12:00am
8-K
r0h9ol6
1 Dec 14
Other Events
12:00am
424B5
h05brz11md62j76gmg
21 Nov 14
Prospectus supplement for primary offering
12:00am
8-K
gcf4uolph6dgg1 kas
20 Nov 14
Galena Biopharma, Inc. announces Purchase Agreement for up to $55.0 Million with Lincoln Park Capital Fund, LLC
12:00am
424B5
74vo9
20 Nov 14
Prospectus supplement for primary offering
12:00am
EFFECT
3cbsw5r
20 Nov 14
Notice of effectiveness
12:00am
CORRESP
074a5c36a2jm4yah
19 Nov 14
Correspondence with SEC
12:00am
8-K
eyeq9ya
7 Nov 14
Departure of Directors or Certain Officers
12:00am
8-K
25jb5o 9ja2djadwrzwi
3 Nov 14
Galena Biopharma Reports Third Quarter 2014 Results
12:00am
8-K
x0wkr2pd4b9
26 Sep 14
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
12:00am
8-K
vsxgdoxr
18 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K/A
ulbhw9gdzc4q3r8cm
26 Aug 14
Departure of Directors or Certain Officers
12:00am
8-K
grx17lovk2zn03ds
22 Aug 14
Departure of Directors or Certain Officers
12:00am
8-K
k38ss wv4ugvm
11 Aug 14
Galena Biopharma Reports Second Quarter 2014 Results
12:00am
8-K
4i2088ysvp8lrxf9w
22 Jul 14
Galena Biopharma Enters into Definitive Agreement to License
12:00am